HEADER TRANSFERASE 26-FEB-22 7Z29 TITLE CRYO-EM STRUCTURE OF NNRTI RESISTANT M184I/E138K MUTANT HIV-1 REVERSE TITLE 2 TRANSCRIPTASE WITH A DNA APTAMER IN COMPLEX WITH NEVIRAPINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXORIBONUCLEASE H,P66 RT; COMPND 5 EC: 2.7.7.49,2.7.7.7,3.1.26.13,3.1.13.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: P66 SUBUNIT; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: P51 RT; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES; COMPND 14 OTHER_DETAILS: P51 SUBUNIT; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: DNA (38-MER); COMPND 17 CHAIN: E; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_TAXID: 11678; SOURCE 4 STRAIN: ISOLATE BH10; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: CODON PLUS RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETDUET-1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 13 ORGANISM_TAXID: 11678; SOURCE 14 STRAIN: ISOLATE BH10; SOURCE 15 GENE: GAG-POL; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: CODON PLUS RIL; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PETDUET-1; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 24 ORGANISM_TAXID: 32630 KEYWDS REVERSE TRANSCRIPTASE MUTANT, RT-APTAMER COMPLEX, NNRTI RESISTANCE, KEYWDS 2 NON-NUCLEOSIDE INHIBITOR, TRANSFERASE EXPDTA ELECTRON MICROSCOPY AUTHOR A.K.SINGH,K.DAS REVDAT 2 03-AUG-22 7Z29 1 JRNL REVDAT 1 20-JUL-22 7Z29 0 JRNL AUTH A.K.SINGH,B.DE WIJNGAERT,M.BIJNENS,K.UYTTERSPROT,H.NGUYEN, JRNL AUTH 2 S.E.MARTINEZ,D.SCHOLS,P.HERDEWIJN,C.PANNECOUQUE,E.ARNOLD, JRNL AUTH 3 K.DAS JRNL TITL CRYO-EM STRUCTURES OF WILD-TYPE AND E138K/M184I MUTANT HIV-1 JRNL TITL 2 RT/DNA COMPLEXED WITH INHIBITORS DORAVIRINE AND RILPIVIRINE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 60119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 35858448 JRNL DOI 10.1073/PNAS.2203660119 REMARK 2 REMARK 2 RESOLUTION. 3.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, EPU, CTFFIND, COOT, RELION, REMARK 3 RELION, RELION, RELION, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 5HP1 REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : CORRELATION COEFFICIENT REMARK 3 OVERALL ANISOTROPIC B VALUE : 163.400 REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.380 REMARK 3 NUMBER OF PARTICLES : 304552 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7Z29 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1292121395. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : NNRTI RESISTANT M184I/E138K REMARK 245 MUTANT HIV-1 REVERSE REMARK 245 TRANSCRIPTASE WITH A DNA REMARK 245 APTAMER IN COMPLEX WITH REMARK 245 NEVIRAPINE; HIV-1 REVERSE REMARK 245 TRANSCRIPTASE P66 SUBUNIT WITH REMARK 245 M184I MUTATION; HIV-1 REVERSE REMARK 245 TRANSCRIPTASE P51 SUBUNIT WITH REMARK 245 E138K MUTATION REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.30 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 1981 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS GLACIOS REMARK 245 DETECTOR TYPE : FEI FALCON III (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 150000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 VAL A 0 REMARK 465 PRO A 1 REMARK 465 ILE A 2 REMARK 465 LYS A 49 REMARK 465 ILE A 50 REMARK 465 GLY A 51 REMARK 465 PRO A 52 REMARK 465 GLU A 53 REMARK 465 LYS A 65 REMARK 465 LYS A 66 REMARK 465 ASP A 67 REMARK 465 SER A 68 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 TRP A 71 REMARK 465 ARG A 72 REMARK 465 LYS A 73 REMARK 465 SER A 134 REMARK 465 ILE A 135 REMARK 465 ASN A 136 REMARK 465 ASN A 137 REMARK 465 GLU A 138 REMARK 465 THR A 139 REMARK 465 PRO A 140 REMARK 465 GLY A 141 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 ILE B 5 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 ARG B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 465 DT E -4 REMARK 465 DA E -3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 VAL A 21 CG1 CG2 REMARK 470 LYS A 22 CG CD CE NZ REMARK 470 GLN A 23 CG CD OE1 NE2 REMARK 470 TRP A 24 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 24 CZ3 CH2 REMARK 470 GLU A 28 CG CD OE1 OE2 REMARK 470 GLU A 29 CG CD OE1 OE2 REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 VAL A 60 CG1 CG2 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LYS B 11 CG CD CE NZ REMARK 470 LYS B 66 CG CD CE NZ REMARK 470 ASP B 67 CG OD1 OD2 REMARK 470 TRP B 88 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 88 CZ3 CH2 REMARK 470 LYS B 103 CG CD CE NZ REMARK 470 ASP B 177 CG OD1 OD2 REMARK 470 GLU B 194 CG CD OE1 OE2 REMARK 470 ILE B 195 CG1 CG2 CD1 REMARK 470 GLN B 197 CG CD OE1 NE2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 GLU B 298 CG CD OE1 OE2 REMARK 470 MET B 357 CG SD CE REMARK 470 DA E -2 P OP1 OP2 O5' C5' C4' O4' REMARK 470 DA E -2 C3' C2' C1' N9 C8 N7 C5 REMARK 470 DA E -2 C6 N6 N1 C2 N3 C4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 DC E 3 N2 DG E 31 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 DG E 19 O4' DG E 19 C4' 0.066 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DC E 3 C5' - C4' - O4' ANGL. DEV. = 9.6 DEGREES REMARK 500 DG E 19 C5' - C4' - O4' ANGL. DEV. = 11.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 20 20.31 -140.68 REMARK 500 ILE A 184 -129.85 46.05 REMARK 500 ASP A 218 -160.50 -72.37 REMARK 500 ALA A 355 13.25 -140.20 REMARK 500 GLU A 413 104.54 -171.32 REMARK 500 ASP A 443 -168.00 -161.67 REMARK 500 MET B 184 -132.25 55.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 307 0.12 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7Z24 RELATED DB: PDB REMARK 900 RELATED ID: EMD-14457 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-14458 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF NNRTI RESISTANT M184I/E138K MUTANT HIV-1 REMARK 900 REVERSE TRANSCRIPTASE WITH A DNA APTAMER IN COMPLEX WITH NEVIRAPINE DBREF 7Z29 A 1 554 UNP P03366 POL_HV1B1 600 1153 DBREF 7Z29 B 1 428 UNP P03366 POL_HV1B1 600 1027 DBREF 7Z29 E -4 33 PDB 7Z29 7Z29 -4 33 SEQADV 7Z29 MET A -1 UNP P03366 INITIATING METHIONINE SEQADV 7Z29 VAL A 0 UNP P03366 EXPRESSION TAG SEQADV 7Z29 CYS A 63 UNP P03366 ILE 662 CONFLICT SEQADV 7Z29 ILE A 184 UNP P03366 MET 783 ENGINEERED MUTATION SEQADV 7Z29 SER A 280 UNP P03366 CYS 879 CONFLICT SEQADV 7Z29 ASN A 498 UNP P03366 ASP 1097 CONFLICT SEQADV 7Z29 LYS B 138 UNP P03366 GLU 737 ENGINEERED MUTATION SEQADV 7Z29 SER B 280 UNP P03366 CYS 879 CONFLICT SEQRES 1 A 556 MET VAL PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS SEQRES 2 A 556 LEU LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP SEQRES 3 A 556 PRO LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE SEQRES 4 A 556 CYS THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE SEQRES 5 A 556 GLY PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA CYS SEQRES 6 A 556 LYS LYS LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP SEQRES 7 A 556 PHE ARG GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU SEQRES 8 A 556 VAL GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS SEQRES 9 A 556 LYS LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR SEQRES 10 A 556 PHE SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR SEQRES 11 A 556 ALA PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY SEQRES 12 A 556 ILE ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS SEQRES 13 A 556 GLY SER PRO ALA ILE PHE GLN SER SER MET THR LYS ILE SEQRES 14 A 556 LEU GLU PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE SEQRES 15 A 556 TYR GLN TYR ILE ASP ASP LEU TYR VAL GLY SER ASP LEU SEQRES 16 A 556 GLU ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG SEQRES 17 A 556 GLN HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS SEQRES 18 A 556 LYS HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR SEQRES 19 A 556 GLU LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL SEQRES 20 A 556 LEU PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN SEQRES 21 A 556 LYS LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR SEQRES 22 A 556 PRO GLY ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG SEQRES 23 A 556 GLY THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU SEQRES 24 A 556 GLU ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU SEQRES 25 A 556 LYS GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS SEQRES 26 A 556 ASP LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN SEQRES 27 A 556 TRP THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU SEQRES 28 A 556 LYS THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR SEQRES 29 A 556 ASN ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE SEQRES 30 A 556 THR THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS SEQRES 31 A 556 PHE LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP SEQRES 32 A 556 TRP THR GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP SEQRES 33 A 556 GLU PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR SEQRES 34 A 556 GLN LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE SEQRES 35 A 556 TYR VAL ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY SEQRES 36 A 556 LYS ALA GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL SEQRES 37 A 556 VAL PRO LEU THR ASN THR THR ASN GLN LYS THR GLU LEU SEQRES 38 A 556 GLN ALA ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU SEQRES 39 A 556 VAL ASN ILE VAL THR ASN SER GLN TYR ALA LEU GLY ILE SEQRES 40 A 556 ILE GLN ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL SEQRES 41 A 556 ASN GLN ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL SEQRES 42 A 556 TYR LEU ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY SEQRES 43 A 556 ASN GLU GLN VAL ASP LYS LEU VAL SER ALA SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN LYS THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN SEQRES 1 E 38 DT DA DA DT DA DC OMC DC OMC DC DC DC DT SEQRES 2 E 38 DT DC DG DG DT DG DC DT DT DT DG DC DA SEQRES 3 E 38 DC DC DG DA DA DG DG DG DG DG DG DG HET OMC E 2 21 HET OMC E 4 21 HET NVP A 901 20 HETNAM OMC O2'-METHYLYCYTIDINE-5'-MONOPHOSPHATE HETNAM NVP 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2- HETNAM 2 NVP B:2',3'-E][1,4]DIAZEPIN-6-ONE HETSYN NVP NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE FORMUL 3 OMC 2(C10 H16 N3 O8 P) FORMUL 4 NVP C15 H14 N4 O HELIX 1 AA1 LYS A 30 GLU A 44 1 15 HELIX 2 AA2 ARG A 78 ARG A 83 1 6 HELIX 3 AA3 HIS A 96 LEU A 100 5 5 HELIX 4 AA4 ASP A 113 VAL A 118 1 6 HELIX 5 AA5 ASP A 121 THR A 128 1 8 HELIX 6 AA6 GLY A 155 ASN A 175 1 21 HELIX 7 AA7 GLU A 194 TRP A 212 1 19 HELIX 8 AA8 THR A 253 SER A 268 1 16 HELIX 9 AA9 VAL A 276 LYS A 281 1 6 HELIX 10 AB1 THR A 296 LYS A 311 1 16 HELIX 11 AB2 ASN A 363 TRP A 383 1 21 HELIX 12 AB3 GLN A 394 GLU A 404 1 11 HELIX 13 AB4 GLN A 475 ASP A 488 1 14 HELIX 14 AB5 SER A 499 ALA A 508 1 10 HELIX 15 AB6 SER A 515 LYS A 528 1 14 HELIX 16 AB7 GLY A 544 SER A 553 1 10 HELIX 17 AB8 GLU B 28 LYS B 43 1 16 HELIX 18 AB9 PHE B 77 GLU B 89 1 13 HELIX 19 AC1 PRO B 97 LYS B 103 5 7 HELIX 20 AC2 GLY B 112 PHE B 116 5 5 HELIX 21 AC3 ASP B 123 TYR B 127 5 5 HELIX 22 AC4 SER B 134 LYS B 138 5 5 HELIX 23 AC5 LYS B 154 ASN B 175 1 22 HELIX 24 AC6 GLU B 194 TRP B 212 1 19 HELIX 25 AC7 HIS B 235 TRP B 239 5 5 HELIX 26 AC8 VAL B 254 TYR B 271 1 18 HELIX 27 AC9 THR B 296 GLU B 312 1 17 HELIX 28 AD1 ASP B 364 TRP B 383 1 20 HELIX 29 AD2 GLN B 394 TRP B 402 1 9 HELIX 30 AD3 THR B 403 TRP B 406 5 4 SHEET 1 AA1 3 SER A 105 ASP A 110 0 SHEET 2 AA1 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AA1 3 VAL A 179 TYR A 183 -1 N VAL A 179 O GLY A 190 SHEET 1 AA2 2 ALA A 129 THR A 131 0 SHEET 2 AA2 2 ARG A 143 GLN A 145 -1 O TYR A 144 N PHE A 130 SHEET 1 AA3 3 PHE A 227 TRP A 229 0 SHEET 2 AA3 3 TYR A 232 LEU A 234 -1 O TYR A 232 N TRP A 229 SHEET 3 AA3 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AA4 5 LYS A 347 TYR A 354 0 SHEET 2 AA4 5 TRP A 337 GLU A 344 -1 N ILE A 341 O LEU A 349 SHEET 3 AA4 5 ILE A 326 LYS A 331 -1 N ILE A 326 O TYR A 342 SHEET 4 AA4 5 LYS A 388 LEU A 391 1 O LYS A 390 N ILE A 329 SHEET 5 AA4 5 TRP A 414 PHE A 416 1 O GLU A 415 N PHE A 389 SHEET 1 AA5 2 HIS A 361 THR A 362 0 SHEET 2 AA5 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 AA6 5 GLN A 464 THR A 470 0 SHEET 2 AA6 5 LEU A 452 THR A 459 -1 N ALA A 455 O VAL A 467 SHEET 3 AA6 5 GLU A 438 GLY A 444 -1 N TYR A 441 O VAL A 458 SHEET 4 AA6 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 AA6 5 LYS A 530 TRP A 535 1 O ALA A 534 N THR A 497 SHEET 1 AA7 3 ILE B 47 SER B 48 0 SHEET 2 AA7 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 AA7 3 ALA B 129 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 AA8 2 PHE B 61 LYS B 64 0 SHEET 2 AA8 2 TRP B 71 LEU B 74 -1 O ARG B 72 N ILE B 63 SHEET 1 AA9 4 VAL B 179 TYR B 183 0 SHEET 2 AA9 4 ASP B 186 SER B 191 -1 O ASP B 186 N TYR B 183 SHEET 3 AA9 4 SER B 105 ASP B 110 -1 N THR B 107 O VAL B 189 SHEET 4 AA9 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 AB1 2 TRP B 252 THR B 253 0 SHEET 2 AB1 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 AB2 3 LYS B 347 ASN B 348 0 SHEET 2 AB2 3 GLN B 336 GLU B 344 -1 N GLU B 344 O LYS B 347 SHEET 3 AB2 3 GLY B 352 ALA B 355 -1 O TYR B 354 N TRP B 337 SHEET 1 AB3 5 LYS B 347 ASN B 348 0 SHEET 2 AB3 5 GLN B 336 GLU B 344 -1 N GLU B 344 O LYS B 347 SHEET 3 AB3 5 ILE B 326 LYS B 331 -1 N ILE B 326 O TYR B 342 SHEET 4 AB3 5 LYS B 388 LEU B 391 1 O LYS B 390 N ALA B 327 SHEET 5 AB3 5 GLU B 413 PHE B 416 1 O GLU B 415 N PHE B 389 LINK O3' DC E 1 P OMC E 2 1555 1555 1.60 LINK O3' OMC E 2 P DC E 3 1555 1555 1.60 LINK O3' DC E 3 P OMC E 4 1555 1555 1.56 LINK O3' OMC E 4 P DC E 5 1555 1555 1.60 CISPEP 1 PRO A 225 PRO A 226 0 -1.89 CISPEP 2 PRO A 420 PRO A 421 0 -0.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000